Meningococcal vaccination rates are low among eligible patients with complement component deficiencies, according to a study of U.S. data. Researchers used a nationwide database to assess uptake of vaccines against...
Changes to vaccination protocols against meningococcal serotype B (MenB) and human papillomavirus (HPV) are some of the most significant in the 2016 immunization schedule released recently by the Advisory Committee on...
New research recently published in the journal Emerging Infectious Diseases shows that the new MenB vaccine Bexsero (routinely offered to UK infants since September 2015) should provide additional protection against a...